Table 4 Dose–response analysis of the association of maternal fever episodes and risk of ASD in offspring, any time during pregnancy and after 12 weeks of gestation to birth (N=79 109)a
Exposure period | Number of fever episodes | ASD N (%) | Non-case N (%) | Crude analysis | Adjusted analysis b | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
OR | 95% CI | P-value | aOR | 95% CI | P-value | ||||||
Any time during pregnancy | 1–2 | 92 (19.41) | 12 976 (16.50) | 1.23 | 0.98 | 1.54 | 0.078 | 1.31 | 1.04 | 1.64 | 0.023 |
⩾3 | 6 (1.27) | 533 (0.68) | 1.95 | 0.87 | 4.39 | 0.107 | 2.15 | 0.95 | 4.84 | 0.066 | |
After 12 weeks | 1–2 | 81 (17.09) | 11 477 (14.60) | 1.22 | 0.96 | 1.55 | 0.111 | 1.30 | 1.02 | 1.66 | 0.033 |
⩾3 | 5 (1.05) | 303 (0.39) | 2.84 | 1.17 | 6.92 | 0.021 | 3.12 | 1.28 | 7.63 | 0.013 |